Brian A Mendelsohn
13PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (13)
Sort by Publication Date:
|Sep 26, 2025
Advanced Antibody-Drug Conjugates Design: Innovation in Linker Chemistry and Site-Specific Conjugation Technologies.Yutaka Matsuda, Jenny R Chang, Brian A Mendelsohn
|Aug 21, 2025
Preclinical Characterization of XB010: A Novel Antibody-Drug Conjugate for the Treatment of Solid Tumors that Targets Tumor-Associated Antigen 5T4.Brian A Mendelsohn, Kathleen R Gogas, Jeffrey N Higaki
|Nov 04, 2024
Preclinical Characterization of XB002, an Anti-Tissue Factor Antibody-Drug Conjugate for the Treatment of Solid Tumors.Seema Kantak, Raffaella Faggioni, Allen G Cai
|Apr 19, 2024
AJICAP-M: Traceless Affinity Peptide Mediated Conjugation Technology for Site-Selective Antibody-Drug Conjugate Synthesis.Yutaka Matsuda, Natsuki Shikida, Noriko Hatada
|Mar 09, 2023
AJICAP Second Generation: Improved Chemical Site-Specific Conjugation Technology for Antibody-Drug Conjugate Production.Tomohiro Fujii, Yutaka Matsuda, Takuya Seki
|Sep 01, 2022
Physical characteristics comparison between maytansinoid-based and auristatin-based antibody-drug conjugates.Tomohiro Fujii, Calliste Reiling, Colette Quinn
Pageof 3
Frequent Collaborators
8 joint publications
Yutaka Matsuda
2 joint publications
Kazutoshi Takahashi
2 joint publications
Seema Kantak
2 joint publications
Jackie Cheng
2 joint publications
Inna Vainshtein
1 joint publications
Kei Yamada
1 joint publications
Tatsuya Okuzumi
1 joint publications
Yuichi Nakahara
1 joint publications
Ayodele O Ogunkoya
1 joint publications
Raffaella Faggioni
